balance equationreview2025-04-30
Difference 1788000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
Revenue
$282.00M
Fiscal year ended 2026-04-30Operating income
$16.72M
Fiscal year ended 2026-04-30Free cash flow
Unavailable
Fiscal year ended 2026-04-30KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported revenue of $282.00M and net income of $9.62M for the fiscal year ended 2026-04-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from KEWAUNEE SCIENTIFIC CORP /DE/’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 | 2018-04-30 | 2017-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $282.00M | $240.47M | $203.76M | $219.49M | $168.87M | $147.47M | $147.54M | $146.55M | $158.05M | $138.56M |
| Cost of revenue | $201.56M | $171.62M | $151.70M | $183.91M | $144.65M | $123.48M | $124.11M | $121.23M | $125.89M | $111.95M |
| Gross profit | $80.44M | $68.86M | $52.05M | $35.59M | $24.22M | $23.99M | $23.43M | $25.32M | $32.16M | $26.61M |
| Operating income | $16.72M | $17.76M | $18.28M | $5.36M | -$2.61M | -$1.32M | -$2.34M | $2.11M | $9.92M | $6.54M |
| Net income | $9.62M | $11.40M | $18.75M | $738.00K | -$6.13M | -$3.67M | -$4.69M | $1.53M | $5.28M | $4.52M |
| Research & development | $898.00K | $919.00K | $920.00K | $1.01M | $990.00K | $1.41M | $1.82M | $1.55M | $1.54M | $1.16M |
| Weighted-average diluted shares | shares 2.98M | shares 2.98M | shares 2.94M | shares 2.90M | shares 2.79M | shares 2.76M | shares 2.75M | shares 2.79M | shares 2.78M | shares 2.73M |
| Pretax income | $13.73M | $14.78M | $13.12M | $4.50M | -$2.48M | -$2.62M | -$2.87M | $2.13M | $9.62M | $6.75M |
| Income tax expense | $3.27M | $3.20M | -$5.94M | $3.14M | $3.52M | $990.00K | $1.76M | $446.00K | $4.16M | $2.13M |
| Diluted EPS | $3.22 | $3.83 | $6.38 | $0.25 | $-2.20 | $-1.33 | $-1.70 | $0.55 | $1.90 | $1.66 |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 | 2018-04-30 | 2017-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $9.95M | $14.94M | $23.27M | $8.08M | $4.43M | $5.21M | $4.36M | $10.65M | $9.72M | $12.51M |
| Total assets | $178.31M | $194.65M | $134.77M | $118.90M | $118.77M | $89.38M | $83.93M | $87.22M | $85.08M | $80.92M |
| Current assets | $105.40M | $118.36M | $96.82M | $87.92M | $91.56M | $60.46M | $54.23M | $65.36M | $64.39M | $59.81M |
| Total liabilities | $101.50M | $128.41M | $78.56M | $80.41M | $82.59M | $47.90M | $45.23M | $39.52M | $36.89M | $37.66M |
| Current liabilities | $48.35M | $53.71M | $40.78M | $40.05M | $42.29M | $34.18M | $27.06M | $32.73M | $27.62M | $26.93M |
| Total equity incl. NCI | $76.81M | $64.46M | $54.76M | $37.41M | $35.69M | $41.24M | $38.42M | $47.10M | $47.73M | $43.46M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $30.53M | $32.85M | $20.68M | $21.89M | $23.80M | $16.52M | $15.33M | $17.21M | $18.55M | $14.94M |
| Accounts receivable | $58.74M | $62.38M | $45.06M | $46.08M | $41.25M | $32.88M | $28.06M | $33.26M | $32.66M | $29.89M |
| Goodwill | $12.49M | $12.49M | $0 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt | $15.08M | $34.68M | Unavailable | Unavailable | Unavailable | Unavailable | $0 | $97.00K | $1.26M | $2.43M |
| Accounts payable | $22.46M | $27.03M | $23.26M | $23.60M | $27.32M | $16.78M | $13.11M | $15.19M | $14.75M | $12.00M |
Cash flow
| Metric | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 | 2018-04-30 | 2017-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $18.63M | $14.78M | $19.56M | -$3.79M | -$7.88M | $912.00K | $4.16M | $2.49M | $3.18M | $11.66M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$3.94M | -$30.90M | -$4.37M | -$4.15M | -$1.91M | -$2.40M | -$2.46M | -$4.21M | -$3.40M | -$2.48M |
| Financing cash flow | -$19.33M | $7.41M | -$3.01M | $14.93M | $11.03M | $1.98M | -$7.46M | $2.33M | -$2.48M | -$2.08M |
| Net change in cash | -$5.55M | -$8.77M | $12.12M | $6.92M | $1.16M | $516.00K | -$5.94M | $198.00K | -$2.98M | $7.28M |
| Stock-based compensation | $2.13M | $1.44M | $1.03M | $886.00K | $729.00K | $634.00K | $251.00K | $197.00K | $355.00K | $199.00K |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $0 | $1.04M | $2.03M | $1.79M | $1.57M |
| Common share repurchases | $0 | $1.60M | $2.00M | $0 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $6.28M | $4.76M | $3.12M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 | 2018-04-30 | 2017-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 28.5% | 28.6% | 25.5% | 16.2% | 14.3% | 16.3% | 15.9% | 17.3% | 20.3% | 19.2% |
| Operating margin | 5.9% | 7.4% | 9.0% | 2.4% | -1.5% | -0.9% | -1.6% | 1.4% | 6.3% | 4.7% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 0.8% | 0.6% | 0.5% | 0.4% | 0.4% | 0.4% | 0.2% | 0.1% | 0.2% | 0.1% |
| Current ratio | 2.18x | 2.20x | 2.37x | 2.20x | 2.17x | 1.77x | 2.00x | 2.00x | 2.33x | 2.22x |
| Revenue YoY growth | 17.3% | 18.0% | -7.2% | 30.0% | 14.5% | -0.0% | 0.7% | -7.3% | 14.1% | Unavailable |
| Net margin | 3.4% | 4.7% | 9.2% | 0.3% | -3.6% | -2.5% | -3.2% | 1.0% | 3.3% | 3.3% |
| R&D / revenue | 0.3% | 0.4% | 0.5% | 0.5% | 0.6% | 1.0% | 1.2% | 1.1% | 1.0% | 0.8% |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 0.20x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 23.8% | 21.7% | -45.3% | 69.8% | Unavailable | Unavailable | Unavailable | 20.9% | 43.3% | 31.5% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open KEQU in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-09-11View SEC filing
10-K · Filed 2026-06-26View SEC filing
10-Q · Filed 2026-03-13View SEC filing
10-Q · Filed 2025-12-12View SEC filing
10-Q · Filed 2025-09-12View SEC filing
10-K · Filed 2025-07-02View SEC filing
Reconciliation checks needing review
3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2024-04-30
Difference 1449000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2023-04-30
Difference 1076000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.